18
18
15
15
14
14
16
16
18
18
20
20
22
22
28
28
12
12
6
6
2016
2007
Company (273)University (8)
1 - 10 of 273
Sort by
Patent
Publication NumberEP 2753333 B1Filing StatusIssued PatentAvailabilityUnknownFiling Date2012-10-10Publication Date2017-06-21
Patent
Publication NumberCN 104010641 BFiling StatusIssued PatentAvailabilityUnknownFiling Date2012-10-10Publication Date2017-04-12
Compounds and their pharmaceutically acceptable salts for treatment of
Patent
Publication NumberCY 1115725 T1Filing StatusOtherAvailabilityUnknownFiling Date2014-11-11Publication Date2017-01-25
Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of
Patent
Publication NumberCY 1115484 T1Filing StatusOtherAvailabilityUnknownFiling Date2014-06-18Publication Date2017-01-04
Ενώσεις δι- και τρι-διυδροξυαρυλίου και τα μεθυλενοδιοξυ ανάλογα τους και φαρμακευτικά αποδεκτοί εστέρες, η σύνθεση τους, φαρμακευτικές συνθέσεις που τις περιέχουν και χρήση τους στην θεραπεία αμυλοειδικών ασθενειών, ειδικότερα Αβ αμυλοείδωση, όπως παρατηρείται στην νόσο Alzheimer, ΙΑΡΡ αμυλοείδωση, όπως παρατηρείται στον διαβήτη τύπου 2, και συνουκλεϊνοπάθειες, όπως παρατηρούνται στην νόσο Parkinson, και παρασκευή φαρμάκων για τέτοια θεραπεία.
Patent
Publication NumberCY 1114949 T1Filing StatusOtherAvailabilityUnknownFiling Date2014-02-20Publication Date2016-12-14
Ενώσεις δι- και τρι-διυδροξυαρυλίου και τα μεθυλενοδιοξυ ανάλογα τους και φαρμακευτικά αποδεκτοί εστέρες, η σύνθεση τους, φαρμακευτικές συνθέσεις που τις περιέχουν και χρήση τους στην θεραπεία αμυλοειδικών ασθενειών, ειδικότερα Αβ αμυλοείδωση, όπως παρατηρείται στην νόσο Alzheimer, ΙΑΡΡ αμυλοείδωση, όπως παρατηρείται στον διαβήτη τύπου 2, και συνουκλεϊνοπάθειες, όπως παρατηρούνται στην νόσο Parkinson, και παρασκευή φαρμάκων για τέτοια θεραπεία.
Patent
Publication NumberAU 2012329274 B2Filing StatusIssued PatentAvailabilityUnknownFiling Date2012-10-10Publication Date2016-11-10
Compounds and their pharmaceutically acceptable salts for treatment of β-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
Patent
Publication NumberUS 9469605Filing StatusIssued PatentAvailabilityUnknownFiling Date2014-06-10Publication Date2016-10-18
This invention relates to the use of bis- and tris-dihydroxyaryl compounds as well as sulfonamides, heteroaryls, tricycloalkyl and their analogs and pharmaceutically acceptable salts, for modulating tau aggregation and alleviating tauopathies, such as Alzheimer's disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and familial frontotemporal dementia/Parkinsonism linked to chromosome 17 (FTDP-17), amyotrophic lateral sclerosis/Parkinsonism…
Patent
Publication NumberUS 9334251Filing StatusIssued PatentAvailabilityUnknownFiling Date2015-06-16Publication Date2016-05-10
Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
Patent
Publication NumberAU 2016201693 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2016-03-17Publication Date2016-04-07
Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of -amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
Patent
Publication NumberMY 156302 AFiling StatusIssued PatentAvailabilityUnknownFiling Date2009-06-26Publication Date2016-01-29
DIHYDROXYARYL COMPOUNDS AND PHARMACEUTICALLY ACCEPTABLE ESTERS, THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THE TREATMENT OF B-AMYLOID DISEASES, SUCH AS OBSERVED IN ALZHEIMER?S DISEASE, AND SYNUCLEINOPATHIES, SUCH AS OBSERVED IN PARKINSON?S DISEASE, AND THE MANUFACTURE OF MEDICAMENTS FOR SUCH TREATMENT.
We found 273 documents that match your Search
Research Grants: 35
Patents: 235
SEC Filings: 3

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in